Grupo Fleury has acquired Hemolab to enhance its healthcare services in Minas Gerais, expanding its presence in a strategically important region.

Target Company Overview

The Grupo Fleury has announced its acquisition of Hemolab, a prominent clinical laboratory located in Conselheiro Lafaiete, Minas Gerais. With over 27 years of established history, Hemolab has built a strong reputation in clinical analysis and vaccination services. The company operates through 15 units across nine municipalities, including Carandaí, Congonhas, and Ouro Branco. Additionally, Hemolab offers home collection services for its clients, further enhancing its accessibility and convenience.

This acquisition marks a significant expansion for Grupo Fleury, which had previously acquired Laboratório Méthodos in southern Minas Gerais in 2022. The incorporation of Hemolab strengthens Fleury’s presence in the B2C market, particularly in Minas Gerais, where they now operate a total of 108 healthcare units, enriched by other respected brands such as Hermes Pardini and LabClass.

Industry Overview in Brazil

Minas Gerais is a region of considerable economic diversity and boasts a strategic geographical position within Brazil. Historically noted for its industrial and agr

View Source

Similar Deals

Lightsmith Group Beep Saúde

2024

Other Home Healthcare Services Brazil
HT3 Investimentos Central da Visão

2024

Other Hospitals, Clinics & Primary Care Services Brazil
Unimed Central de Serviços Medical Virtual Market (MVM)

2024

Other Healthcare Facilities & Services (NEC) Brazil
Unimed Central de Serviços Medical Virtual Market

2024

Other Managed Healthcare (NEC) Brazil
União Química Bayer's manufacturing facility

2022

Other Proprietary & Advanced Pharmaceuticals Brazil

Grupo Fleury

invested in

Hemolab

in 2025

in a Other deal

Disclosed details

Enterprise Value: $2,000M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert